V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20223531 | 20084717 | 1.71 | 90.3 | Palliative (P) | 2020-06-05 | 2020-07-21 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100744750 |
| 20223534 | 20084718 | 1.76 | 78.6 | Palliative (P) | 2019-04-25 | 2019-05-01 | Enzalutamide | N | N | OCTREOTIDE | 101708718 |
| 20223536 | 20084719 | null | 85.8 | Curative (C) | 2018-01-20 | 2018-01-25 | Enzalutamide | N | Y | ENZALUTAMIDE | 100864230 |
| 20223537 | 20084720 | 1.7 | 86 | Palliative (P) | 2019-07-01 | 2019-07-02 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101096190 |
| 20223545 | 20084721 | 1.82 | null | Curative (C) | 2017-04-20 | 2017-05-18 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101021219 |
| 20223554 | 20084722 | 1.75 | 63.2 | Palliative (P) | 2016-12-08 | 2016-12-30 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101673743 |
| 20223557 | 20084723 | 1.75 | 71 | 03 | null | 2017-12-20 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 101021718 |
| 20223560 | 20084724 | 1.6 | 56.4 | Curative (C) | 2018-02-13 | 2018-02-13 | Capecitabine + Cisplatin + RT | 02 | N | ECF | 100847334 |
| 20223566 | 20084725 | 0 | 72.1 | 03 | 2017-04-21 | 2017-05-13 | Enzalutamide | 99 | N | CETUXIMAB | 100414544 |
| 20223572 | 20084726 | 1.86 | 90.95 | Neo-adjuvant (N) | 2016-10-19 | 2016-10-20 | Enzalutamide | N | N | CETUXIMAB | 100592349 |
| 20223580 | 20084727 | 1.54 | 84 | null | null | 2018-08-09 | Enzalutamide | null | null | CARBOPLATIN | 101622996 |
| 20223581 | 20084728 | 1.57 | 84 | Palliative (P) | 2019-03-14 | 2019-04-13 | Enzalutamide | 02 | N | CISPLATIN | 100697401 |
| 20223587 | 20084729 | 1.8 | 71.6 | null | 2019-01-26 | 2019-01-27 | Cetuximab + Oxaliplatin + MdG Load | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100672923 |
| 20223589 | 20084730 | 1.8 | 72 | Palliative (P) | 2016-06-26 | 2016-07-10 | ECF | 2 | N | ECF | 101208605 |
| 20223595 | 20084731 | 1.74 | 0 | Neo-adjuvant (N) | 2015-11-13 | 2015-11-14 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101294063 |
| 20223596 | 20084732 | 1.73 | 134 | Palliative (P) | 2017-05-26 | 2017-06-01 | Enzalutamide | 02 | N | CARBOPLATIN | 100581635 |
| 20223600 | 20084733 | 1.65 | 112.9 | null | 2018-01-08 | 2018-01-10 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100961767 |
| 20223603 | 20084734 | 1.75 | 63.6 | Neo-adjuvant (N) | 2018-08-18 | 2018-08-21 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100595329 |
| 20223604 | 20084735 | 1.55 | 61.8 | Palliative (P) | 2018-08-02 | 2018-08-03 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100314664 |
| 20223607 | 20084736 | 1.63 | 69.5 | null | 2017-06-22 | 2017-06-23 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101833113 |
| 20223614 | 20084737 | 1.83 | 98 | Curative (C) | 2016-09-25 | 2016-09-25 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101269118 |
| 20223624 | 20084738 | 1.48 | 0 | Neo-adjuvant (N) | 2020-06-26 | 2020-07-14 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100219151 |
| 20223633 | 20084739 | 1.83 | null | Neo-adjuvant (N) | 2019-07-30 | 2019-08-06 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101546590 |
| 20223640 | 20084740 | 1.6 | 69 | Palliative (P) | 2017-08-04 | 2017-08-04 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100893618 |
| 20223641 | 20084741 | 1.7 | 52.1 | Palliative (P) | 2019-02-10 | 2019-02-10 | Enzalutamide | 02 | null | TRASTUZUMAB | 100297243 |
| 20223642 | 20084742 | 1.73 | 128 | Palliative (P) | 2019-02-02 | 2019-02-02 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100197834 |
| 20223650 | 20084743 | 1.57 | 70.1 | Palliative (P) | null | 2016-06-11 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101236268 |
| 20223652 | 20084744 | 1.7 | 58.2 | null | null | 2017-07-06 | Enzalutamide | 02 | null | CISPLATIN | 100136756 |
| 20223653 | 20084745 | 1.8 | 87.9 | Neo-adjuvant (N) | 2016-01-03 | 2016-01-04 | Enzalutamide | 02 | Y | CETUXIMAB + OXALIPLATIN + MDG | 101842318 |
| 20223654 | 20084746 | 1.81 | 59.8 | Palliative (P) | 2016-10-04 | 2016-10-04 | Capecitabine + Cisplatin + RT | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100059344 |
| 20223655 | 20084747 | 1.58 | 86.5 | Palliative (P) | null | 2016-11-04 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101835774 |
| 20223659 | 20084748 | 1.8 | 65.3 | null | 2019-02-15 | 2019-03-01 | Enzalutamide | 02 | null | OXALIPLATIN + RALTITREXED | 100303334 |
| 20223668 | 20084749 | 1.64 | 99 | Neo-adjuvant (N) | 2017-02-27 | 2017-03-13 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100902221 |
| 20223676 | 20084750 | 1.67 | 58.5 | null | 2019-05-03 | 2019-05-07 | Enzalutamide | 02 | null | ECF | 100144595 |
| 20223679 | 20084751 | 1.65 | 95 | null | 2016-12-25 | 2016-12-25 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 101351269 |
| 20223680 | 20084752 | 1.8 | 64.1 | Palliative (P) | 2019-12-08 | 2019-12-08 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100836691 |
| 20223684 | 20084753 | 1.69 | 69.7 | null | 2019-01-18 | 2019-01-18 | Enzalutamide | 02 | null | TRASTUZUMAB | 100899784 |
| 20223685 | 20084754 | 1.72 | 57.9 | Neo-adjuvant (N) | 2017-07-01 | 2017-07-02 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101636255 |
| 20223687 | 20084755 | 1.62 | 91.2 | null | 2017-04-01 | 2017-04-03 | Enzalutamide | 02 | null | SCALOP-2 TRIAL | 101554408 |
| 20223690 | 20084756 | 1.76 | 109 | Palliative (P) | 2019-01-11 | 2019-01-17 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100105675 |
| 20223694 | 20084757 | 1.84 | 134.3 | Palliative (P) | 2018-11-05 | 2018-11-05 | Carboplatin AUC 2 - 5 | 2 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100787194 |
| 20223695 | 20084758 | 1.7 | 69.15 | Palliative (P) | 2016-12-14 | 2016-12-21 | Enzalutamide | 02 | N | CISPLATIN | 100732908 |
| 20223713 | 20084759 | 1.78 | 112 | Palliative (P) | 2018-02-22 | 2018-04-03 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101557816 |
| 20223715 | 20084760 | 1.53 | 80 | Curative (C) | 2015-10-30 | 2015-11-10 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101149286 |
| 20223721 | 20084761 | 1.88 | 0 | Adjuvant (A) | null | 2017-02-02 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101204757 |
| 20223722 | 20084762 | 1.7 | 77.8 | Curative (C) | 2017-07-25 | 2017-08-03 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100869897 |
| 20223732 | 20084763 | 1.56 | 66.5 | Palliative (P) | 2017-06-18 | 2017-06-25 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100851387 |
| 20223738 | 20084764 | 1.61 | 67 | Curative (C) | 2016-09-29 | 2016-10-03 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 101163850 |
| 20223741 | 20084765 | 1.68 | 62 | 03 | 2016-02-25 | 2016-02-25 | Enzalutamide | 02 | N | CARBOPLATIN | 100284227 |
| 20223749 | 20084766 | 1.88 | 70 | Palliative (P) | 2020-02-24 | 2020-03-11 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101360662 |